Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
Huntsman Cancer Institute at University of Utah
2088
mi
from 02139
Salt Lake City, UT
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
2088
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
The Angeles Clinic & Research Institute
2588
mi
from 02139
Los Angeles, CA
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
The Angeles Clinic & Research Institute
2588
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
Tennessee Oncology - Nashville; The Sarah Cannon Research Institute
940
mi
from 02139
Nashville, TN
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
Tennessee Oncology - Nashville; The Sarah Cannon Research Institute
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University; Henry Joyce Cancer Clinic
941
mi
from 02139
Nashville, TN
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University; Henry Joyce Cancer Clinic
941
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
1018
mi
from 02139
Jacksonville, FL
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
1018
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
A Phase 1/2, Open-Label, Safety, Tolerability, and Efficacy Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Combination Chemotherapy in Treating Patients With Sarcoma
A Pilot Study for Soft Tissue Sarcoma
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
Combination Chemotherapy in Treating Patients With Sarcoma
A Pilot Study for Soft Tissue Sarcoma
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated:  12/31/1969
University of Colorado
1760
mi
from 02139
Aurora, CO
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated: 12/31/1969
University of Colorado
1760
mi
from 02139
Aurora, CO
Click here to add this to my saved trials
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
184
mi
from 02139
New York, NY
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
184
mi
from 02139
New York, NY
Click here to add this to my saved trials
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated:  12/31/1969
Sarah Cannon Research Inst
940
mi
from 02139
Nashville, TN
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated: 12/31/1969
Sarah Cannon Research Inst
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated:  12/31/1969
University of Texas M.D. Anderson Cancer Center
1606
mi
from 02139
Houston, TX
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1606
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated:  12/31/1969
Hospital Universitario Vall d'Hebron
3645
mi
from 02139
Barcelona,
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
A Phase Ib Open-Label Study Evaluating the Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Bevacizumab and Immunotherapy When Administered in Patients With Gastrointestinal and Other Tumors
Status: Enrolling
Updated: 12/31/1969
Hospital Universitario Vall d'Hebron
3645
mi
from 02139
Barcelona,
Click here to add this to my saved trials
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Borland-Groover Clinic
1018
mi
from 02139
Jacksonville, FL
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Borland-Groover Clinic
1018
mi
from 02139
Jacksonville, FL
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Indiana University Hospital
804
mi
from 02139
Indianapolis, IN
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Indiana University Hospital
804
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Indianapolis Gastroenterology & Hepatology, Inc.
803
mi
from 02139
Indianapolis, IN
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Indianapolis Gastroenterology & Hepatology, Inc.
803
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
1079
mi
from 02139
Rochester, MN
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
856
mi
from 02139
Chicago, IL
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
856
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Baystate Hospital
78
mi
from 02139
Springfield, MA
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Baystate Hospital
78
mi
from 02139
Springfield, MA
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Clinical Research Professionals, LLC
1045
mi
from 02139
Saint Louis, MO
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Clinical Research Professionals, LLC
1045
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
NYU
188
mi
from 02139
New York, NY
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
NYU
188
mi
from 02139
New York, NY
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Columbia University
180
mi
from 02139
New York, NY
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Columbia University
180
mi
from 02139
New York, NY
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Asheville Gastroenterology Associates, P.A.
771
mi
from 02139
Asheville, NC
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Asheville Gastroenterology Associates, P.A.
771
mi
from 02139
Asheville, NC
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
268
mi
from 02139
Philadelphia, PA
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
268
mi
from 02139
Philadelphia, PA
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
Virginia Gastroenterology institute
483
mi
from 02139
Suffolk, VA
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
Virginia Gastroenterology institute
483
mi
from 02139
Suffolk, VA
Click here to add this to my saved trials
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated:  12/31/1969
University of South Alabama
1239
mi
from 02139
Mobile, AL
Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.
Multicenter, Prospective, Randomized Study Comparing the Diagnostic Yield of Colon Capsule Endoscopy Versus Computed Tomographic Colonography in a Screening Population
Status: Enrolling
Updated: 12/31/1969
University of South Alabama
1239
mi
from 02139
Mobile, AL
Click here to add this to my saved trials
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
929
mi
from 02139
Madison, WI
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
929
mi
from 02139
Madison, WI
Click here to add this to my saved trials
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated:  12/31/1969
Rutgers Cancer Institute of New Jersey
216
mi
from 02139
New Brunswick, NJ
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
216
mi
from 02139
New Brunswick, NJ
Click here to add this to my saved trials
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated:  12/31/1969
Penn State Cancer Institute
323
mi
from 02139
Hershey, PA
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated: 12/31/1969
Penn State Cancer Institute
323
mi
from 02139
Hershey, PA
Click here to add this to my saved trials
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated:  12/31/1969
University of Illinois Cancer Center
849
mi
from 02139
Chicago, IL
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated: 12/31/1969
University of Illinois Cancer Center
849
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated:  12/31/1969
Michigan State University
680
mi
from 02139
Lansing, MI
Ribociclib and Bicalutamide in AR+ TNBC
A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024
Status: Enrolling
Updated: 12/31/1969
Michigan State University
680
mi
from 02139
Lansing, MI
Click here to add this to my saved trials
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Status: Enrolling
Updated:  12/31/1969
Yale Medical Center
mi
from 02139
New Haven, CT
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Status: Enrolling
Updated: 12/31/1969
Yale Medical Center
mi
from 02139
New Haven, CT
Click here to add this to my saved trials
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Status: Enrolling
Updated:  12/31/1969
Providence Cancer Center
2526
mi
from 02139
Portland, OR
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Status: Enrolling
Updated: 12/31/1969
Providence Cancer Center
2526
mi
from 02139
Portland, OR
Click here to add this to my saved trials
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
1605
mi
from 02139
Houston, TX
A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
An Open-Label, Multicenter, Dose Escalation And Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumor Malignancies
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
1605
mi
from 02139
Houston, TX
Click here to add this to my saved trials
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of Southern California
2586
mi
from 02139
Los Angeles, CA
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Southern California
2586
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Hackensack Medical Center, Mountainside Hospital
192
mi
from 02139
Montclair, NJ
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Hackensack Medical Center, Mountainside Hospital
192
mi
from 02139
Montclair, NJ
Click here to add this to my saved trials
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
St. Michael's Medical Center
194
mi
from 02139
Newark, NJ
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
St. Michael's Medical Center
194
mi
from 02139
Newark, NJ
Click here to add this to my saved trials
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated:  12/31/1969
M.D. Anderson Cancer Center
1605
mi
from 02139
Houston, TX
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
A Prospective Validation Study of a Rapid Point-of-Care Breath Test for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
M.D. Anderson Cancer Center
1605
mi
from 02139
Houston, TX
Click here to add this to my saved trials
HDCRT Plus Pembrolizumab in Advanced Malignancies
A Pilot Study to Assess the Combination of High-Dose Conformal Radiation Therapy (HDCRT) and Pembrolizumab in Modulating Local and Systemic T-cell Responses in Advanced Malignancies
Status: Enrolling
Updated:  12/31/1969
University of Virginia
493
mi
from 02139
Charlottesville, VA
HDCRT Plus Pembrolizumab in Advanced Malignancies
A Pilot Study to Assess the Combination of High-Dose Conformal Radiation Therapy (HDCRT) and Pembrolizumab in Modulating Local and Systemic T-cell Responses in Advanced Malignancies
Status: Enrolling
Updated: 12/31/1969
University of Virginia
493
mi
from 02139
Charlottesville, VA
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
There are 5 sites in different cities in Australia
mi
from 02139
Camperdown,
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
There are 5 sites in different cities in Australia
mi
from 02139
Camperdown,
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Banner MD Anderson Cancer Center
2282
mi
from 02139
Gilbert, AZ
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Banner MD Anderson Cancer Center
2282
mi
from 02139
Gilbert, AZ
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Karmanos Cancer Institute/Wayne State University
609
mi
from 02139
Detroit, MI
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Karmanos Cancer Institute/Wayne State University
609
mi
from 02139
Detroit, MI
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
1036
mi
from 02139
Saint Louis, MO
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
CCCN
2367
mi
from 02139
Las Vegas, NV
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
CCCN
2367
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Ruttenberg Cancer Center, Mount Sinai Hospital
mi
from 02139
New York, NY
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Ruttenberg Cancer Center, Mount Sinai Hospital
mi
from 02139
New York, NY
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Levine Cancer Institute, Carolinas HealthCare System
719
mi
from 02139
Charlotte, NC
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Levine Cancer Institute, Carolinas HealthCare System
719
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
601
mi
from 02139
Durham, NC
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
601
mi
from 02139
Durham, NC
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
UPMC Cancer Center
475
mi
from 02139
Pittsburgh, PA
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
UPMC Cancer Center
475
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated:  12/31/1969
Vanderbilt-Ingram Cancer Center
941
mi
from 02139
Nashville, TN
Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Varlitinib Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer as Second Line Systemic Therapy
Status: Enrolling
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center
941
mi
from 02139
Nashville, TN
Click here to add this to my saved trials